Joinn Laboratories(China)Co.,Ltd. (HKG:6127)

Hong Kong · Delayed Price · Currency is HKD

20.32

+2.09 (11.46%)

Jul 10, 2026, 4:08 PM HKT

3.46% (1Y)

Market Cap	33.50B +119.1%
Revenue (ttm)	1.92B -14.9%
Net Income	562.74M +27.8%
EPS	0.78 +33.4%
Shares Out	n/a
PE Ratio	59.53
Forward PE	629.86
Dividend	0.14 (0.70%)
Ex-Dividend Date	Jun 22, 2026

Volume	11,051,278
Open	18.23
Previous Close	18.23
Day's Range	17.96 - 21.24
52-Week Range	15.13 - 28.70
Beta	0.80
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 29, 2026

About HKG:6127

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics DMPK studies, and pharmacology and efficacy studies. Its Clinical Trial and Related Services segment provide clinical contract research organization s... [Read more]

Industry Diagnostics & Research

Sector Healthcare

Founded 1995

Employees 2,649

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 6127

Financial Performance

In 2025, HKG:6127's revenue was 1.66 billion, a decrease of -17.87% compared to the previous year's 2.02 billion. Earnings were 297.84 million, an increase of 302.08%.

Financial numbers in CNY Financial Statements